UNLABELLED: Human bocaviruses (HBoVs) may be grouped into respiratory (HBoV1) and enteric (HBoV2-4) types. We examined this association of HBoV types and clinical symptoms in 955 children who had acute gastroenteritis (AGE, n = 172), acute respiratory tract infection (ARTI, n = 545) or symptoms of both (n = 238). Both nasal swab and stool specimens were studied for such patients. HBoV1 DNA was detected in 6.2 % of patients with ARTI and 9.2 % of patients with symptoms of both ARTI and AGE, but in only 1.7 % of patients with AGE alone. In about one half of the cases, HBoV1 was detected concomitantly in nasal swab and stool samples. HBoV2 was found in stool samples of patients with AGE (5.8 %), ARTI (5.1 %) and symptoms of both (5.5 %) but only rarely in nasal swabs. HBoV3 was found in the stools, but not in nasal swabs, in 0.6, 1.1 and 0.8 % of patients with, respectively, AGE, ARTI and both. HBoV4 was not found. All but one HBoV-positive stool sample of AGE patients contained a known gastroenteritis virus (rotavirus, norovirus, sapovirus, astrovirus or enteric adenovirus) that was probably responsible for the symptoms of the respective case. Sera of 30 HBoV-positive patients were available, and IgM antibodies for HBoVs were found in ten cases and HBoV DNA in eight of these. CONCLUSIONS: HBoV2 and HBoV3 were more commonly found in stool than in nasal swab samples, but the findings could not be causally linked with AGE. HBoV1 was commonly found in stool samples during ARTI, with or without gastrointestinal symptoms.
UNLABELLED: Human bocaviruses (HBoVs) may be grouped into respiratory (HBoV1) and enteric (HBoV2-4) types. We examined this association of HBoV types and clinical symptoms in 955 children who had acute gastroenteritis (AGE, n = 172), acute respiratory tract infection (ARTI, n = 545) or symptoms of both (n = 238). Both nasal swab and stool specimens were studied for such patients. HBoV1 DNA was detected in 6.2 % of patients with ARTI and 9.2 % of patients with symptoms of both ARTI and AGE, but in only 1.7 % of patients with AGE alone. In about one half of the cases, HBoV1 was detected concomitantly in nasal swab and stool samples. HBoV2 was found in stool samples of patients with AGE (5.8 %), ARTI (5.1 %) and symptoms of both (5.5 %) but only rarely in nasal swabs. HBoV3 was found in the stools, but not in nasal swabs, in 0.6, 1.1 and 0.8 % of patients with, respectively, AGE, ARTI and both. HBoV4 was not found. All but one HBoV-positive stool sample of AGE patients contained a known gastroenteritis virus (rotavirus, norovirus, sapovirus, astrovirus or enteric adenovirus) that was probably responsible for the symptoms of the respective case. Sera of 30 HBoV-positive patients were available, and IgM antibodies for HBoVs were found in ten cases and HBoV DNA in eight of these. CONCLUSIONS: HBoV2 and HBoV3 were more commonly found in stool than in nasal swab samples, but the findings could not be causally linked with AGE. HBoV1 was commonly found in stool samples during ARTI, with or without gastrointestinal symptoms.
Authors: Tobias Allander; Martti T Tammi; Margareta Eriksson; Annelie Bjerkner; Annika Tiveljung-Lindell; Björn Andersson Journal: Proc Natl Acad Sci U S A Date: 2005-08-23 Impact factor: 11.205
Authors: Kalle Kantola; Lea Hedman; Jane Arthur; Abdiwahab Alibeto; Eric Delwart; Tuomas Jartti; Olli Ruuskanen; Klaus Hedman; Maria Söderlund-Venermo Journal: J Infect Dis Date: 2011-09-15 Impact factor: 5.226
Authors: Kalle Kantola; Mohammadreza Sadeghi; Jenni Antikainen; Juha Kirveskari; Eric Delwart; Klaus Hedman; Maria Söderlund-Venermo Journal: J Clin Microbiol Date: 2010-09-15 Impact factor: 5.948
Authors: Cristiana M Nascimento-Carvalho; Maria-Regina A Cardoso; Mira Meriluoto; Kaisa Kemppainen; Kalle Kantola; Olli Ruuskanen; Klaus Hedman; Maria Söderlund-Venermo Journal: J Med Virol Date: 2012-02 Impact factor: 2.327
Authors: Tobias Allander; Tuomas Jartti; Shawon Gupta; Hubert G M Niesters; Pasi Lehtinen; Riikka Osterback; Tytti Vuorinen; Matti Waris; Annelie Bjerkner; Annika Tiveljung-Lindell; Bernadette G van den Hoogen; Timo Hyypiä; Olli Ruuskanen Journal: Clin Infect Dis Date: 2007-02-14 Impact factor: 9.079
Authors: G La Rosa; G Purpari; A Guercio; S Di Bella; F Gucciardi; Y T R Proroga; M Pisanu; S Della Libera; M Iaconelli; E Suffredini Journal: Appl Environ Microbiol Date: 2018-03-19 Impact factor: 4.792
Authors: A H L Bruning; P Susi; H Toivola; A Christensen; M Söderlund-Venermo; K Hedman; H Aatola; A Zvirbliene; J O Koskinen Journal: New Microbes New Infect Date: 2016-02-09
Authors: Kalle Kantola; Lea Hedman; Laura Tanner; Ville Simell; Marjaana Mäkinen; Juulia Partanen; Mohammadreza Sadeghi; Riitta Veijola; Mikael Knip; Jorma Ilonen; Heikki Hyöty; Jorma Toppari; Olli Simell; Klaus Hedman; Maria Söderlund-Venermo Journal: PLoS One Date: 2015-09-29 Impact factor: 3.240